相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of maintenance erlotinib in Asian patients with advanced non-small-cell lung cancer: A subanalysis of the phase III, randomized SATURN study
Yi-Long Wu et al.
LUNG CANCER (2012)
Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapy
Seung Tae Kim et al.
LUNG CANCER (2012)
Treatment of Brain Metastases: Chemotherapy
Sean A. Grimm
CURRENT ONCOLOGY REPORTS (2012)
Biomarkers of clinical benefit for anti-epidermal growth factor receptor agents in patients with non-small-cell lung cancer
A. G. Pallis et al.
BRITISH JOURNAL OF CANCER (2011)
Efficacy of increased-dose erlotinib for central nervous system metastases in non-small cell lung cancer patients with epidermal growth factor receptor mutation
Yosuke Togashi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Medical Management of Patients With Brain Tumors
Amy A. Pruitt
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2011)
Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation
R. Porta et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Erlotinib Accumulation in Brain Metastases from Non-small Cell Lung Cancer: Visualization by Positron Emission Tomography in a Patient Harboring a Mutation in the Epidermal Growth Factor Receptor
Britta Weber et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Pulsatile high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer
Christian Grommes et al.
NEURO-ONCOLOGY (2011)
Multimodality treatment of brain metastases: an institutional survival analysis of 275 patients
Ameer L. Elaimy et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2011)
Multimodality management of non-small cell lung cancer patients with brain metastases
Serena Ricciardi et al.
CURRENT OPINION IN ONCOLOGY (2010)
High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancer
Jennifer L. Clarke et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study
Federico Cappuzzo et al.
LANCET ONCOLOGY (2010)
Risk of Intracranial Hemorrhage and Cerebrovascular Accidents in Non-small Cell Lung Cancer Brain Metastasis Patients
Geetika Srivastava et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective for leptomeningeal metastasis from non-small cell lung cancer patients with sensitive EGFR mutation or other predictive factors of good response for EGFR TKI
Hyeon Gyu Yi et al.
LUNG CANCER (2009)
Gefitinib as palliative therapy for lung adenocarcinoma metastatic to the brain
Chi Wu et al.
LUNG CANCER (2007)
Plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite OSI-420
Alberto Broniscer et al.
CLINICAL CANCER RESEARCH (2007)
Update in the treatment of brain Metastases from lung cancer
Amanda L. Schwer et al.
CLINICAL LUNG CANCER (2006)
Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases - A randomized controlled trial
Hidefumi Aoyama et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Whole-brain radiotherapy in the management of brain metastasis
D Khuntia et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Erlotinib in previously treated non-small-cell lung cancer
FA Shepherd et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Gefitinib is active in patients with brain metastases from non-small cell lung cancer and response is related to skin toxicity
CH Chiu et al.
LUNG CANCER (2005)
Gefitinib in patients with brain metastases from non-small-cell lung cancer:: a prospective trial
GL Ceresoli et al.
ANNALS OF ONCOLOGY (2004)
Effect of gefitinib ('Iressa', ZD1839) on brain metastases in patients with advanced non-small-cell lung cancer
K Hotta et al.
LUNG CANCER (2004)
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
DW Andrews et al.
LANCET (2004)
Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment
N Normanno et al.
ENDOCRINE-RELATED CANCER (2003)
Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment -: Risk factors analysis
GL Ceresoli et al.
CANCER (2002)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
